About Brunel
Brunel is a company based in Centurion (South Africa) founded in 1974 by Louis Nel and Dawie De Bruin. It operates as a Reseller / Distribution and B2B2C. Brunel offers products and services including Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets. Brunel operates in a competitive market with competitors including AmerisourceBergen, Activo Health, Rand Pharmaceutical Distributors, Anmarate and Siyeza Fine Chem, among others.
- Headquarter Centurion, South Africa
- Founders Louis Nel, Dawie De Bruin
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Brunel Laboratoria (Pty) Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
RMB Corvest
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brunel
Brunel offers a comprehensive portfolio of products and services, including Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets.
Various healthcare products are offered for diverse needs.
Packaging materials are provided for pharmaceutical products.
Cardiovascular tablets are included in the portfolio.
Funding Insights of Brunel
Investors in Brunel
Brunel has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include RMB Corvest, Calibre Capital and Umoya Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in South Africa
|
Locked | Locked | Locked | |
|
Umoya Capital Partners is engaged in providing investment capital to private businesses.
|
Locked | Locked | Locked | |
|
Offers investment management services focused on portfolio construction and risk assessment.
|
Locked | Locked | Locked |
Investor details for Brunel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brunel
Investment portfolio details for Brunel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brunel
Detailed financials for Brunel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brunel Comparisons
Peer comparison for Brunel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brunel
Brunel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Activo Health, Rand Pharmaceutical Distributors, Anmarate and Siyeza Fine Chem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by Activo Health in South Africa.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed in South Africa by the company.
|
|
| Locked | Locked | Locked |
R&D company focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
Distributor of pharmaceutical products
|
Detailed competitors of Brunel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brunel
Complete news archive for Brunel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brunel
Brunel was founded in 1974 and raised its 1st funding round 48 years after it was founded.
Brunel is headquartered in Centurion, South Africa. It is registered at Centurion, Gauteng, South Africa.
Paul Jonker is the current CEO of Brunel.
Brunel Laboratoria is established as a privately owned pharmaceutical company based in South Africa. The company is engaged in the production, distribution, and management of a wide range of healthcare brands and products. Solutions are provided across sectors including oral health, haircare, eye care, vitamins, sun protection, and probiotics. A custom-built distribution center is utilized to ensure efficient delivery from manufacturer to client. With over five decades of expertise, strategic partnerships are maintained to uphold quality and compliance in the supply chain.
Brunel's top competitors include AmerisourceBergen, Activo Health and Anmarate.
Brunel offers Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets.
Brunel has 3 investors. Key investors include RMB Corvest, Calibre Capital, and Umoya Capital Partners.